Dr. reddy's laboratories announces the launch of chlordiazepoxide hydrochloride and clidinium bromide capsules, usp in the u.s. market

Hyderabad, india & princeton, n.j.--(business wire)--dr. reddy's laboratories ltd. (bse: 500124, nse: drreddy, nyse: rdy, nseifsc: drreddy, along with its subsidiaries together referred to as “dr. reddy's”) today announced the launch of chlordiazepoxide hydrochloride and clidinium bromide capsules usp, 5 mg/2.5 mg, a therapeutic equivalent generic version of librax® (chlordiazepoxide hydrochloride and clidinium bromide) approved by the u.s. food and drug administration (usfda). the librax® bran
RDY Ratings Summary
RDY Quant Ranking